1. Home
  2. PLUR vs FOXX Comparison

PLUR vs FOXX Comparison

Compare PLUR & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • FOXX
  • Stock Information
  • Founded
  • PLUR 2001
  • FOXX 2017
  • Country
  • PLUR Israel
  • FOXX United States
  • Employees
  • PLUR N/A
  • FOXX N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • FOXX
  • Sector
  • PLUR Health Care
  • FOXX
  • Exchange
  • PLUR Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • PLUR 36.9M
  • FOXX 30.5M
  • IPO Year
  • PLUR N/A
  • FOXX N/A
  • Fundamental
  • Price
  • PLUR $3.90
  • FOXX $4.00
  • Analyst Decision
  • PLUR Strong Buy
  • FOXX
  • Analyst Count
  • PLUR 1
  • FOXX 0
  • Target Price
  • PLUR $12.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • PLUR 11.1K
  • FOXX 24.5K
  • Earning Date
  • PLUR 11-11-2025
  • FOXX 11-18-2025
  • Dividend Yield
  • PLUR N/A
  • FOXX N/A
  • EPS Growth
  • PLUR N/A
  • FOXX N/A
  • EPS
  • PLUR N/A
  • FOXX N/A
  • Revenue
  • PLUR $1,336,000.00
  • FOXX $65,919,166.00
  • Revenue This Year
  • PLUR $97.38
  • FOXX N/A
  • Revenue Next Year
  • PLUR $293.97
  • FOXX N/A
  • P/E Ratio
  • PLUR N/A
  • FOXX N/A
  • Revenue Growth
  • PLUR 309.82
  • FOXX 1941.75
  • 52 Week Low
  • PLUR $3.33
  • FOXX $2.45
  • 52 Week High
  • PLUR $7.13
  • FOXX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 41.43
  • FOXX 37.13
  • Support Level
  • PLUR $3.60
  • FOXX $4.09
  • Resistance Level
  • PLUR $4.00
  • FOXX $4.78
  • Average True Range (ATR)
  • PLUR 0.19
  • FOXX 0.26
  • MACD
  • PLUR -0.01
  • FOXX 0.04
  • Stochastic Oscillator
  • PLUR 29.70
  • FOXX 0.00

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: